# Mitral Regurgitation Treatment in Advanced Heart Failure

Study · id `cardio:ct-nct05292716` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05292716](<https://clinicaltrials.gov/study/NCT05292716>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05292716

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 172 participants.

## Technical summary

Registry record NCT05292716. Randomized; no masking; primary purpose other. Start 2021-04-21 (actual); primary completion 2025-04-21 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 172 participants (planned count; ClinicalTrials.gov record NCT05292716, source copy `cardio:ctgov-nct05292716-2024-08-05`, retrieved 2026-10-26)
- Started: 2021-04-21 (actual) (ClinicalTrials.gov record NCT05292716, source copy `cardio:ctgov-nct05292716-2024-08-05`, retrieved 2026-10-26)
- Primary completion: 2025-04-21 (anticipated) (ClinicalTrials.gov record NCT05292716, source copy `cardio:ctgov-nct05292716-2024-08-05`, retrieved 2026-10-26)
- Completion: 2026-04-21 (anticipated) (ClinicalTrials.gov record NCT05292716, source copy `cardio:ctgov-nct05292716-2024-08-05`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT05292716, source copy `cardio:ctgov-nct05292716-2024-08-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05292716-2024-08-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Mitral Regurgitation Treatment in Advanced Heart Failure
- Acronym: MITRADVANCE
- Condition: Heart Failure
- Condition: Mitral Regurgitation
- Intervention (Device): MitraClip
- Lead sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry intervention name matches this record: MitraClip (`cardio:mitraclip`)

## Provenance

Content hash: 636b2810f3f95f38536869dfa1f4c8f9584a6a4c881beeea5bfe3ba2b7af6611
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
